Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering.

Clarissa Q Pimentel Ana Cristina de Medeiros RibeiroAndrea Y ShimabucoPercival Degrava Sampaio-BarrosJúlio César B MoraesClaudia G SchainbergCelio Roberto GonçalvesElaine P LeonLéonard De Vinci K KupaSandra G PasotoNádia Emi AikawaClovis A SilvaEloisa S Bonfa Carla Gonçalves Schahin Saad

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2024)

This study provided novel data that anti-IFX antibodies is a parameter for reduced tapering survival, reinforcing its detection to guide clinical decision. Additionally, we confirmed in a long-term cohort the anti-IFX antibody association with worse IFX performance and as predictor of the second TNFi good clinical response.

Keyphrases

emergency department
electronic health record
disease activity
systemic lupus erythematosus
decision making
deep learning
drug induced